For people with Alzheimers and other neurodegenerative brain conditions, GLP-1s have shown mixed results
In another study conducted in mice with Alzheimer disease in the final stage, intraperitoneal liraglutide improved spatial memory, reduced amyloid deposition and inflammation, and increased dentate gyrus neurogenesis, suggesting that, besides exerting preventive effects, this GLP-1RA may reverse some of the key pathological findings of Alzheimer disease
Individual outcomes vary depending on the dose, titration pace, adherence, and baseline health
Oral semaglutide depends on a daily absorption event that cannot be "banked" or spread out
To maintain cellular integrity under these conditions, plants activate coordinated defense responses involving antioxidant metabolism, hormonal signaling, and transcriptional reprogramming (Sachdev et al., 2021)